P008. Referral and Diagnosis of Hereditary Transthyretin Amyloidosis by Heart Failure Nursing Specialists in the United States: Insights From a Genetic Testing Program

Hereditary transthyretin amyloidosis (hATTR or ATTRv [variant]) is a progressive and fatal disease caused by mutations in the transthyretin gene (TTR) that result in the deposition of misfolded TTR protein in major organs and systems, leading to multisystem dysfunction. Patients often experience a mixed phenotype of both cardiomyopathy and polyneuropathy. Early diagnosis, which can be facilitated with genetic testing, is key to achieving optimal patient outcomes.

Source: Heart and Lung - June 5, 2021 Category: Intensive Care Authors: Christopher Bell, Jill Dolinksy, Aaron Gabriel, Arvind Narayana, Kemi Olugemo, Meghan Towne Tags: Research Source Type: research